These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A structure-activity relationship study of spirolactones. Contribution of the cyclopropane ring to antimineralocorticoid activity. Chinn LJ, Salamon KW, Desai BN. J Med Chem; 1981 Sep; 24(9):1103-7. PubMed ID: 6270335 [Abstract] [Full Text] [Related]
14. [Ultrastructure of the thyroid gland following adrenalectomy and administration to adrenalectomized animals of hydrocortisone or DOCA]. Cherniaev AN. Probl Endokrinol (Mosk); 1972 Aug; 18(1):58-62. PubMed ID: 5061556 [No Abstract] [Full Text] [Related]
15. Bioassay of a new aldosterone antagonist and evaluation of a simple method of quantitative comparison. McInnes GT, Shelton JR, Asbury MJ, Harrison IR, Clarke JM, Ramsay LE, Venning GR. Clin Pharmacol Ther; 1981 Aug; 30(2):218-25. PubMed ID: 7249505 [Abstract] [Full Text] [Related]
18. Mineralocorticoid activity of 19-nor-DOC and 19-OH-DOC in adrenalectomized rat. Perrone RD, Bengele HH, Dale SL, Melby JC, Alexander EA. Am J Physiol; 1982 May; 242(5):E305-8. PubMed ID: 7081431 [Abstract] [Full Text] [Related]
19. Ring D oxygenated Spirolactones. Characterization of human metabolic product of spironolactone. Chinn LJ, Brown EA, Mizuba SS, Karim A. J Med Chem; 1977 Mar; 20(3):352-5. PubMed ID: 845867 [Abstract] [Full Text] [Related]